Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLCO1B1 and APOE polymorphisms in atorvastatin response and adverse effects
ChiCTR1800018634Phase 4Not yet recruiting
- Sponsor
- Fifth Affiliated Hospital of Guangzhou Medical University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atorvastatin in hyperlipidemia, sponsored by Fifth Affiliated Hospital of Guangzhou Medical University. Primary endpoints: SLCO1B1 genotype and APOE genotype. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on ChiCTR1800018634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018634.